October 26, 2024Diabetology & Metabolic Syndrome21 citationsOpen Access

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

XCXiaomei Chen XZXuge Zhang XXXiang Xiang

Key Points

Key points are not available for this paper at this time.

Abstract

GLP-1 RAs significantly reduce cardiovascular risk in high-risk T2DM patients, especially with combination therapy and in those with chronic kidney disease. However, further research is needed to confirm their long-term effects.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Chen et al. (Sat,) studied this question.

synapsesocial.com/papers/696a9b70f6ea43690e0a154b https://doi.org/https://doi.org/10.1186/s13098-024-01497-4

AI से पूछें

Bookmark

View Full Paper